Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapy.
Mizuhara K, Fujii N, Meguri Y, Takahashi T, Aoe M, Nakamura M, Seike K, Sando Y, Fujii K, Abe M, Sumii Y, Urata T, Fujiwara Y, Saeki K, Asada N, Ennishi D, Nishimori H, Matsuoka KI, Maeda Y. Mizuhara K, et al. Among authors: sumii y. Int J Hematol. 2020 Sep;112(3):422-426. doi: 10.1007/s12185-020-02886-x. Epub 2020 Apr 27. Int J Hematol. 2020. PMID: 32342335
Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipient.
Fujiwara Y, Matsuoka KI, Iwamoto M, Sumii Y, Abe M, Mizuhara K, Urata T, Saeki K, Meguri Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Sugita J, Kobayashi H, Oto T, Maeda Y. Fujiwara Y, et al. Among authors: sumii y. Int J Hematol. 2020 Dec;112(6):871-877. doi: 10.1007/s12185-020-02967-x. Epub 2020 Aug 17. Int J Hematol. 2020. PMID: 32803699
5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy.
Sando Y, Matsuoka KI, Sumii Y, Kondo T, Ikegawa S, Sugiura H, Nakamura M, Iwamoto M, Meguri Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Utsunomiya A, Oka T, Maeda Y. Sando Y, et al. Among authors: sumii y. Sci Rep. 2020 Oct 14;10(1):17237. doi: 10.1038/s41598-020-74174-x. Sci Rep. 2020. PMID: 33057055 Free PMC article.
Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease.
Iwamoto M, Ikegawa S, Kondo T, Meguri Y, Nakamura M, Sando Y, Sugiura H, Sumii Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Shibakura M, Maeda Y, Matsuoka KI. Iwamoto M, et al. Among authors: sumii y. Bone Marrow Transplant. 2021 Apr;56(4):956-959. doi: 10.1038/s41409-020-01100-0. Epub 2020 Oct 30. Bone Marrow Transplant. 2021. PMID: 33128029 No abstract available.
Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab.
Ikegawa S, Meguri Y, Mizuhara K, Fukumi T, Kobayashi H, Sumii Y, Kondo T, Sando Y, Iwamoto M, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Fujisawa Y, Imai T, Maeda Y, Matsuoka KI. Ikegawa S, et al. Among authors: sumii y. Leukemia. 2021 Mar;35(3):929-931. doi: 10.1038/s41375-021-01167-8. Epub 2021 Feb 17. Leukemia. 2021. PMID: 33597730 No abstract available.
Author Correction: 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy.
Sando Y, Matsuoka KI, Sumii Y, Kondo T, Ikegawa S, Sugiura H, Nakamura M, Iwamoto M, Meguri Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Utsunomiya A, Oka T, Maeda Y. Sando Y, et al. Among authors: sumii y. Sci Rep. 2021 Mar 15;11(1):6420. doi: 10.1038/s41598-021-86066-9. Sci Rep. 2021. PMID: 33723351 Free PMC article. No abstract available.
Total body irradiation-based haploidentical hematopoietic stem cell transplantation using posttransplant cyclophosphamide after administration of inotuzumab ozogamicin: A case report.
Abe M, Fujii N, Mizuhara K, Urata T, Sumii Y, Fujiwara Y, Seike K, Sando Y, Nakamura M, Fujii K, Saeki K, Meguri Y, Asada N, Ennishi D, Nishimori H, Matsuoka KI, Maeda Y. Abe M, et al. Among authors: sumii y. Leuk Res Rep. 2021 Apr 22;15:100241. doi: 10.1016/j.lrr.2021.100241. eCollection 2021. Leuk Res Rep. 2021. PMID: 34007785 Free PMC article.
Pretransplant Short-Term Exposure of Donor Graft Cells to ITK Selective Inhibitor Ameliorates Acute Graft-versus-Host Disease by Inhibiting Effector T Cell Differentiation while Sparing Regulatory T Cells.
Kondo T, Ikegawa S, Fukumi T, Sumii Y, Sugiura H, Sando Y, Nakamura M, Meguri Y, Iwamoto M, Maeda Y, Matsuoka KI. Kondo T, et al. Among authors: sumii y. Immunohorizons. 2021 Jun 10;5(6):424-437. doi: 10.4049/immunohorizons.2100042. Immunohorizons. 2021. PMID: 34112701 Free article.
69 results